Former CDER Chief Galson Moving To Amgen
This article was originally published in The Pink Sheet Daily
Executive Summary
Galson, who went to FDA in 2001 to deal with post-marketing surveillance issues, will arrive in time for Aranesp advisory committee meeting.
You may also be interested in...
Amgen Shortens Epogen, Procrit Shelf-lives Following Recall
Firm is working with vial manufacturers to determine the cause of the delamination.
Amgen Shortens Epogen, Procrit Shelf-lives Following Recall
Firm is working with vial manufacturers to determine the cause of the delamination.
PDUFA’s Fairy Godmother: Woodcock Steps Into Breach As Acting CDER Chief
Faced with the departure of Steven Galson as CDER director just as major new drug safety authorities have been bestowed upon FDA, Commissioner Andrew von Eschenbach has turned to former CDER director Janet Woodcock to provide a practiced hand on the wheel of change until a permanent replacement can be found